Berberine can lower blood glucose and may potentiate the effects of diabetes medications, including metformin, sulfonylureas, and insulin, potentially causing hypoglycaemia
The meta-analysis demonstrated consistent benefits across different GLP-1 receptor agonist preparations and dosing protocols [63]
But its not just the tooth and nothing but the tooth that supposedly may be affected
More than 40% of respondents who have diabetes and about a quarter of those who have heart disease said they have used GLP-1 drugs

Your GP can: Assess your current weight, BMI, and metabolic health to determine clinical need Review existing treatment options that are currently licensed and available in the UK, which may include orlistat, naltrexone/bupropion (Mysimba), semaglutide 2.4 mg (Wegovy approved by the MHRA for weight management and subject to NICE guidance on eligibility, service setting, and treatment duration), and tirzepatide (Mounjaro check current MHRA and NICE status at the time of reading, as licensing and commissioning arrangements may have been updated) Discuss eligibility for NHS Tier 3 or Tier 4 specialist weight management services , in line with NICE guidance on obesity management, where pharmacotherapy is used as an adjunct to structured lifestyle intervention Signpost you to relevant clinical trials via the Be Part of Research portal or ClinicalTrials.gov if you wish to explore participation in retatrutide research It is important to approach information about investigational medicines with appropriate caution

Green tea Okay, this one isnt technically a food, but the drink deserves mentioning